Comparing Lantus vs Novolog
| Lantus (insulin glargine) | Novolog (insulin aspart) |
|
|---|
| Lantus (insulin glargine) | Novolog (insulin aspart) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Lantus is a long-acting insulin that only needs to be injected once a day, subcutaneously. It is available as a prefilled pen (Lantus Solostar) or a 10mL vial. Hypoglycemia is the most common side... View more |
Prescription only
Prescribed for Type 2 Diabetes, Diabetes - Type 1, Diabetic Ketoacidosis, Nonketotic Hyperosmolar Syndrome. Novolog may also be used for purposes not listed in this medication guide. |
Related suggestions Type 2 Diabetes
Diabetes, Type 1
Popular comparisons
|
|||||||||||||||
| More about Lantus (insulin glargine) | More about Novolog (insulin aspart) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Lantus has an average rating of 6.5 out of 10 from a total of 41 ratings on Drugs.com. 59% of reviewers reported a positive effect, while 29% reported a negative effect. |
Novolog has an average rating of 5.5 out of 10 from a total of 32 ratings on Drugs.com. 31% of reviewers reported a positive effect, while 34% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
|
View all Lantus side effects |
View all Novolog side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Lantus prices |
View all Novolog prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
| Other insulin glargine brands include: Basaglar, Lantus SoloStar, Rezvoglar, Semglee, Toujeo Max SoloStar, Toujeo SoloStar | Other insulin aspart brands include: Fiasp, Merilog, Merilog SoloStar, NovoLog FlexPen, NovoLog PenFill, ReliOn NovoLog | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
24 hours |
1.5 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 392 drugs are known to interact with Lantus:
|
A total of 392 drugs are known to interact with Novolog:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
|
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
April 20, 2000 |
June 07, 2000 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.